PharmaCyte Biotech Requests Pre-IND Meeting with FDA for its Pancreatic Cancer Clinical Trial Biotech Investing
Keryx Biopharmaceuticals to Host Conference Call of Third Quarter 2016 Financial Results Biotech Investing
Aeterna Zentaris Announces US$7,560,000 Registered Direct Offering of Common Shares and Warrants Biotech Investing
